Biogen Inc. (BIIB)
USD 146.79
(-2.56%)
USD 146.79
(-2.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.83 Billion | 10.17 Billion | 10.98 Billion | 13.44 Billion | 14.37 Billion | 13.45 Billion |
| Cost of Revenue | 2.53 Billion | 2.27 Billion | 2.1 Billion | 1.8 Billion | 1.95 Billion | 1.81 Billion |
| Gross Profit | 7.3 Billion | 7.89 Billion | 8.87 Billion | 11.63 Billion | 12.42 Billion | 11.63 Billion |
| Operating Expenses | 5.2 Billion | 4.99 Billion | 6.06 Billion | 7.19 Billion | 5.38 Billion | 5.63 Billion |
| Selling, General and Administrative Expenses | 2.54 Billion | 2.4 Billion | 2.67 Billion | 2.5 Billion | 2.37 Billion | 2.1 Billion |
| Research and Development Expenses | 2.46 Billion | 2.23 Billion | 2.5 Billion | 3.99 Billion | 2.28 Billion | 2.59 Billion |
| Other Expenses | - | 358.5 Million | 888.5 Million | 697.7 Million | 731.5 Million | 11 Million |
| Cost and Expenses | 7.73 Billion | 7.27 Billion | 8.17 Billion | 8.99 Billion | 7.34 Billion | 7.45 Billion |
| Operating Income | 1.29 Billion | 2.32 Billion | 2.84 Billion | 4.55 Billion | 7.04 Billion | 5.88 Billion |
| Interest Expense | 246.9 Million | 246.6 Million | 253.6 Million | 222.5 Million | 187.4 Million | 200.6 Million |
| Income Tax Expense | 135.3 Million | 632.8 Million | 52.5 Million | 992.3 Million | 1.15 Billion | 1.42 Billion |
| Earnings before Tax | 1.29 Billion | 3.59 Billion | 1.74 Billion | 5.04 Billion | 7.12 Billion | 5.89 Billion |
| Net Income | 1.16 Billion | 3.04 Billion | 1.55 Billion | 4 Billion | 5.88 Billion | 4.43 Billion |
| Earnings Per Share Basic | 8.02 | 20.97 | 10.44 | 24.86 | 31.47 | 21.62 |
| Earnings Per Share Diluted | 7.97 | 20.87 | 10.40 | 24.80 | 31.42 | 21.58 |
| Weighted Average Shares Outstanding | 144.7 Million | 145.3 Million | 149.1 Million | 160.9 Million | 187.1 Million | 204.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 145.6 Million | 146 Million | 149.6 Million | 161.3 Million | 187.4 Million | 205.3 Million |
| Gross Margin | 0.74 | 0.78 | 0.81 | 0.87 | 0.86 | 0.86 |
| EBIT Margin | 0.24 | 0.26 | 0.33 | 0.36 | 0.52 | 0.51 |
| Profit Margin | 0.12 | 0.30 | 0.14 | 0.30 | 0.41 | 0.33 |
| EBITDA | 2.37 Billion | 4.35 Billion | 2.48 Billion | 5.73 Billion | 7.77 Billion | 6.75 Billion |
| Earnings Before Tax Margin | 0.13 | 0.23 | 0.26 | 0.34 | 0.49 | 0.44 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.46 Billion | 2.35 Billion | 2.2 Billion | 9.83 Billion | 2.38 Billion | 2.53 Billion |
| Cost of Revenue | 638.7 Million | 704.8 Million | 689.8 Million | 2.53 Billion | 618.3 Million | 659.6 Million |
| Gross Profit | 1.82 Billion | 1.64 Billion | 1.51 Billion | 7.3 Billion | 1.76 Billion | 1.87 Billion |
| Operating Expenses | 1.37 Billion | 995.8 Million | 965.1 Million | 5.47 Billion | 1.31 Billion | 1.63 Billion |
| Selling, General and Administrative Expenses | 588.4 Million | 553.8 Million | 581.5 Million | - | 608.5 Million | 788.2 Million |
| Research and Development Expenses | 542.7 Million | 442 Million | 383.6 Million | - | 570.9 Million | 736.3 Million |
| Other Expenses | 245 Million | -2 Million | -1.9 Million | -3.5 Million | 1.6 Million | -300 Million |
| Cost and Expenses | 2.01 Billion | 1.7 Billion | 1.65 Billion | 8 Billion | 1.92 Billion | 2.29 Billion |
| Operating Income | 451 Million | 652.4 Million | 545.4 Million | 1.29 Billion | 291.6 Million | -141.2 Million |
| Interest Expense | - | 61.3 Million | 69.2 Million | 246.9 Million | 71.5 Million | 63.8 Million |
| Income Tax Expense | 62.5 Million | 115.1 Million | 71.4 Million | 135.3 Million | 42.7 Million | -72.9 Million |
| Earnings before Tax | 451 Million | 698.7 Million | 464.8 Million | 1.29 Billion | 291.6 Million | -141.2 Million |
| Net Income | 388.5 Million | 583.6 Million | 393.4 Million | 1.16 Billion | 249.7 Million | -68.1 Million |
| Earnings Per Share Basic | 2.67 | 4.01 | 2.71 | - | 1.72 | -0.47 |
| Earnings Per Share Diluted | 2.66 | 4.00 | 2.70 | - | 1.71 | -0.47 |
| Weighted Average Shares Outstanding | 145.6 Million | 145.6 Million | 145.2 Million | 144.7 Million | 144.9 Million | 144.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 145.9 Million | 145.9 Million | 145.9 Million | 145.6 Million | 145.7 Million | 144.8 Million |
| Gross Margin | 0.74 | 0.70 | 0.69 | 0.74 | 0.74 | 0.74 |
| EBIT Margin | 0.18 | 0.34 | 0.31 | - | 0.26 | 0.15 |
| Profit Margin | 0.16 | 0.25 | 0.18 | 0.12 | 0.10 | -0.03 |
| EBITDA | 451 Million | 811.2 Million | 693 Million | - | 623.2 Million | 371.7 Million |
| Earnings Before Tax Margin | 0.18 | 0.28 | 0.25 | 0.13 | 0.12 | -0.06 |
CTXDF
CLARA
0QON
TCNNF
PRDO
GPPRF